Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Urinary Tract Infections
  • 1.2.3 Surgical Site Infections
  • 1.2.4 Hospital-acquired Pneumonia
  • 1.2.5 BloodStream Infections
  • 1.2.6 Gastrointestinal Infections
• 1.3 Market by Application
  • 1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 ASCs
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2016-2027)
• 2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
  • 2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
  • 2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
• 2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
  • 2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
  • 2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
  • 2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
  • 2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
  • 3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2016-2021)
  • 3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
• 3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
• 3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
  • 3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
• 3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
• 3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
• 3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type

• 4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
• 4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application

• 5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
• 5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
• 6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
  • 6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
  • 6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
  • 6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
• 6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
  • 6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
  • 6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
  • 6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
• 6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
  • 6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
  • 6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
• 7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
  • 7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
  • 7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
  • 7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
• 7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
  • 7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
  • 7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
  • 7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
• 7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
  • 7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
  • 7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
• 8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
  • 8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
  • 8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
  • 8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
• 9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
  • 9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
  • 9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
  • 9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
• 9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
  • 9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
  • 9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
  • 9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
• 9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
  • 9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
  • 9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
• 10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
  • 10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
  • 10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
  • 10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Abbott Business Overview
  • 11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.1.5 Abbott Recent Development
• 11.2 Accelerate Diagnostics
  • 11.2.1 Accelerate Diagnostics Company Details
  • 11.2.2 Accelerate Diagnostics Business Overview
  • 11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.2.5 Accelerate Diagnostics Recent Development
• 11.3 BD
  • 11.3.1 BD Company Details
  • 11.3.2 BD Business Overview
  • 11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.3.5 BD Recent Development
• 11.4 bioMrieux
  • 11.4.1 bioMrieux Company Details
  • 11.4.2 bioMrieux Business Overview
  • 11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.4.5 bioMrieux Recent Development
• 11.5 Bio-Rad
  • 11.5.1 Bio-Rad Company Details
  • 11.5.2 Bio-Rad Business Overview
  • 11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.5.5 Bio-Rad Recent Development
• 11.6 DiaSorin Molecular
  • 11.6.1 DiaSorin Molecular Company Details
  • 11.6.2 DiaSorin Molecular Business Overview
  • 11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.6.5 DiaSorin Molecular Recent Development
• 11.7 F. Hoffmann-La Roche
  • 11.7.1 F. Hoffmann-La Roche Company Details
  • 11.7.2 F. Hoffmann-La Roche Business Overview
  • 11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.7.5 F. Hoffmann-La Roche Recent Development
• 11.8 Luminex
  • 11.8.1 Luminex Company Details
  • 11.8.2 Luminex Business Overview
  • 11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.8.5 Luminex Recent Development
• 11.9 Meridian Bioscience
  • 11.9.1 Meridian Bioscience Company Details
  • 11.9.2 Meridian Bioscience Business Overview
  • 11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.9.5 Meridian Bioscience Recent Development
• 11.10 OpGen
  • 11.10.1 OpGen Company Details
  • 11.10.2 OpGen Business Overview
  • 11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.10.5 OpGen Recent Development
• 11.11 QIAGEN
  • 11.11.1 QIAGEN Company Details
  • 11.11.2 QIAGEN Business Overview
  • 11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.11.5 QIAGEN Recent Development
• 11.12 Quidel
  • 11.12.1 Quidel Company Details
  • 11.12.2 Quidel Business Overview
  • 11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.12.5 Quidel Recent Development
• 11.13 Thermo Fisher Scientific
  • 11.13.1 Thermo Fisher Scientific Company Details
  • 11.13.2 Thermo Fisher Scientific Business Overview
  • 11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.13.5 Thermo Fisher Scientific Recent Development
• 11.14 Trinity Biotech
  • 11.14.1 Trinity Biotech Company Details
  • 11.14.2 Trinity Biotech Business Overview
  • 11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.14.5 Trinity Biotech Recent Development
• 11.15 Danaher
  • 11.15.1 Danaher Company Details
  • 11.15.2 Danaher Business Overview
  • 11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
  • 11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
  • 11.15.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer